Cargando…

Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family

Consecutive patient cultures (140) of Mycobacteriium tuberculosis were collected from five Russian civilian and prison tuberculosis laboratories and analyzed for rifampin (rpoB) and isoniazid resistance (inhA, katG, ahpC); transmission of Beijing family isolates; and the importance of prison and pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Drobniewski, Francis, Balabanova, Yanina, Ruddy, Michael, Weldon, Laura, Jeltkova, Katya, Brown, Timothy, Malomanova, Nadezdna, Elizarova, Elvira, Melentyey, Alexander, Mutovkin, Ebgeny, Zhakharova, Svetlana, Fedorin, Ivan
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2738537/
https://www.ncbi.nlm.nih.gov/pubmed/12453364
http://dx.doi.org/10.3201/eid0811.020507
_version_ 1782171520578093056
author Drobniewski, Francis
Balabanova, Yanina
Ruddy, Michael
Weldon, Laura
Jeltkova, Katya
Brown, Timothy
Malomanova, Nadezdna
Elizarova, Elvira
Melentyey, Alexander
Mutovkin, Ebgeny
Zhakharova, Svetlana
Fedorin, Ivan
author_facet Drobniewski, Francis
Balabanova, Yanina
Ruddy, Michael
Weldon, Laura
Jeltkova, Katya
Brown, Timothy
Malomanova, Nadezdna
Elizarova, Elvira
Melentyey, Alexander
Mutovkin, Ebgeny
Zhakharova, Svetlana
Fedorin, Ivan
author_sort Drobniewski, Francis
collection PubMed
description Consecutive patient cultures (140) of Mycobacteriium tuberculosis were collected from five Russian civilian and prison tuberculosis laboratories and analyzed for rifampin (rpoB) and isoniazid resistance (inhA, katG, ahpC); transmission of Beijing family isolates; and the importance of prison and previous therapy in drug resistance. Rifampin, isoniazid, and multidrug resistance occurred in 58.2%, 51.6%, and 44.7% of cultures, respectively; 80% of prison cultures were rifampin resistant. Spoligotyping and variable number tandem repeat (VNTR) fingerprinting divided the isolates into 43 groups. Spoligotyping demonstrated that a high proportion (68.1%) of patients were infected with Beijing family strains and that most (69.1%) were rifampin resistant; the highest proportion (81.6%) occurred in prison. One VNTR subgroup (42435) comprised 68 (72.3%) of the Beijing isolates with a small number of IS6110 types; 50 (73.5%) were rifampin resistant. Rifampin-resistant Beijing isolates are dominant within the patient population, especially among prisoners, and threaten treatment programs.
format Text
id pubmed-2738537
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-27385372009-09-16 Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family Drobniewski, Francis Balabanova, Yanina Ruddy, Michael Weldon, Laura Jeltkova, Katya Brown, Timothy Malomanova, Nadezdna Elizarova, Elvira Melentyey, Alexander Mutovkin, Ebgeny Zhakharova, Svetlana Fedorin, Ivan Emerg Infect Dis Research Consecutive patient cultures (140) of Mycobacteriium tuberculosis were collected from five Russian civilian and prison tuberculosis laboratories and analyzed for rifampin (rpoB) and isoniazid resistance (inhA, katG, ahpC); transmission of Beijing family isolates; and the importance of prison and previous therapy in drug resistance. Rifampin, isoniazid, and multidrug resistance occurred in 58.2%, 51.6%, and 44.7% of cultures, respectively; 80% of prison cultures were rifampin resistant. Spoligotyping and variable number tandem repeat (VNTR) fingerprinting divided the isolates into 43 groups. Spoligotyping demonstrated that a high proportion (68.1%) of patients were infected with Beijing family strains and that most (69.1%) were rifampin resistant; the highest proportion (81.6%) occurred in prison. One VNTR subgroup (42435) comprised 68 (72.3%) of the Beijing isolates with a small number of IS6110 types; 50 (73.5%) were rifampin resistant. Rifampin-resistant Beijing isolates are dominant within the patient population, especially among prisoners, and threaten treatment programs. Centers for Disease Control and Prevention 2002-11 /pmc/articles/PMC2738537/ /pubmed/12453364 http://dx.doi.org/10.3201/eid0811.020507 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Drobniewski, Francis
Balabanova, Yanina
Ruddy, Michael
Weldon, Laura
Jeltkova, Katya
Brown, Timothy
Malomanova, Nadezdna
Elizarova, Elvira
Melentyey, Alexander
Mutovkin, Ebgeny
Zhakharova, Svetlana
Fedorin, Ivan
Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family
title Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family
title_full Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family
title_fullStr Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family
title_full_unstemmed Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family
title_short Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family
title_sort rifampin- and multidrug-resistant tuberculosis in russian civilians and prison inmates: dominance of the beijing strain family
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2738537/
https://www.ncbi.nlm.nih.gov/pubmed/12453364
http://dx.doi.org/10.3201/eid0811.020507
work_keys_str_mv AT drobniewskifrancis rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily
AT balabanovayanina rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily
AT ruddymichael rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily
AT weldonlaura rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily
AT jeltkovakatya rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily
AT browntimothy rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily
AT malomanovanadezdna rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily
AT elizarovaelvira rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily
AT melentyeyalexander rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily
AT mutovkinebgeny rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily
AT zhakharovasvetlana rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily
AT fedorinivan rifampinandmultidrugresistanttuberculosisinrussianciviliansandprisoninmatesdominanceofthebeijingstrainfamily